B. Ünlü

发表

Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression

P. Reitsma, P. Kuppen, H. Versteeg, 2015, Journal of thrombosis and haemostasis : JTH.

Effects of tumor-expressed coagulation factors on cancer progression and venous thrombosis: is there a key factor?

H. Versteeg, B. Ünlü, 2014, Thrombosis research.

Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma

J. Rak, N. Mackman, H. Versteeg, 2016, Oncotarget.

Theme 1: Pathogenesis of venous thromboembolism (and post-thrombotic syndrome).

S. Diamond, P. Reitsma, R. Nieuwland, 2015, Thrombosis research.

Tumor‐expressed microRNAs associated with venous thromboembolism in colorectal cancer

P. Kuppen, S. Kiełbasa, H. Mei, 2022, Research and practice in thrombosis and haemostasis.

Cancer‐associated thrombosis: The search for the holy grail continues

H. Versteeg, B. Ünlü, 2018, Research and practice in thrombosis and haemostasis.

Integrin regulation by tissue factor promotes cancer stemness and metastatic dissemination in breast cancer

P. Kuppen, H. Versteeg, W. Ruf, 2022, Oncogene.

Interplay between alternatively spliced Tissue Factor and full length Tissue Factor in modulating coagulant activity of endothelial cells.

H. Versteeg, B. Ünlü, V. Bogdanov, 2017, Thrombosis research.

Assessment of breast cancer progression and metastasis during a hypercoagulable state induced by silencing of antithrombin in a xenograft mouse model.

H. Versteeg, J. Buijs, B. V. van Vlijmen, 2022, Thrombosis research.

Genes associated with venous thromboembolism in colorectal cancer patients

J. Westerga, P. Kuppen, W. Arindrarto, 2018, Journal of thrombosis and haemostasis : JTH.

Tumor-expressed factor VII is associated with survival and regulates tumor progression in breast cancer

P. Kuppen, E. Stanganello, H. Versteeg, 2023, Blood advances.